Learn More
 Following a study in Senegal (1990–1995) in which the relative efficacy of a diphtheria-tetanus-acellular pertussis vaccine (DTaP) was compared with that of a diphtheria-tetanus-whole-cell pertussis(More)
A diphtheria and tetanus toxoid two-component acellular pertussis vaccine (DTaP), consisting of 25 μg glutaraldehyde-detoxified pertussis toxin (PT) and 25 μg native filamentous hemagglutinin (FHA),(More)
  • 1